Home › Crohn's Disease › Ohio › Cleveland
Pag-aaral pangklinika para sa Crohn's Disease sa Cleveland, OH
19 pag-aaral para sa Crohn's Disease ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Cleveland (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Nagre-recruitPhase 3
- Great Lakes Gastroenterology Research, LLC ( Site 5016), Mentor · 22 mi ang layo
Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- University Hospitals Cleveland Medical Center, Cleveland
- UH Minoff Health Center, Chagrin Falls · 17 mi ang layo
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Nagre-recruitPhase 4
- Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi ang layo
Non-nutritive Sweeteners in Inflammatory Bowel Disease
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- University Hospitals Cleveland Medical Center, Cleveland
- UH Minoff Health Center, Chagrin Falls · 17 mi ang layo
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 2
- Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi ang layo
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 3
- Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi ang layo
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 3
- University Hospitals Cleveland Medical Center-Site Number: 8400073, Cleveland
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 3
- Cleveland Clinic - Cleveland /ID# 256453, Cleveland
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Nagre-recruitPhase 4
- Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi ang layo
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 3
- Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi ang layo
Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD
Nagre-recruit
- Cleveland Clinic, Cleveland
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 3
- UH Cleveland Medical Center /ID# 262188, Cleveland
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Nagre-recruitPhase 3
- University Children's Clinic, Cleveland
- Cleveland Clinic, Cleveland
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
Nagre-recruitPhase 4
- UH/Rainbow Babies and Children's Hospital, Cleveland
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Nagre-recruitPhase 3
- University Hospitals Cleveland Medical Center - 11100 Euclid Ave, Cleveland
Precise Infliximab Exposure and Pharmacodynamic Control
Nagre-recruitPhase 2/3
- Cleveland Clinic Children's Hospital, Cleveland
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Nagre-recruitPhase 3
- University Hospitals Cleveland Medical Center, Cleveland
Treatment of Moderate to Severe Refractory Crohn's Disease
Nagre-recruitPhase 1/2
- Cleveland Clinic, Cleveland
Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
Nagre-recruitObservasyonal na pag-aaral
- Cleveland Clinic Foundation, Cleveland
Pag-aaral para sa Crohn's Disease sa ibang lungsod
- New York City, NY35 pag-aaral
- Boston, MA19 pag-aaral
- Miami, FL19 pag-aaral
- St. Louis, MO19 pag-aaral
- Tyler, TX17 pag-aaral
- Houston, TX17 pag-aaral
- Orlando, FL17 pag-aaral
- Atlanta, GA17 pag-aaral
- San Antonio, TX15 pag-aaral
- Los Angeles, CA15 pag-aaral
- San Diego, CA15 pag-aaral
- Colorado Springs, CO13 pag-aaral
Iba pang pag-aaral sa Cleveland
- Non-Small Cell Lung Cancer43 pag-aaral
- Kanser (lahat ng uri)36 pag-aaral
- Kanser sa Suso35 pag-aaral
- Kanser sa Prostate34 pag-aaral
- Pagkabigo ng Puso33 pag-aaral
- Kanser sa Ovary30 pag-aaral
- Metastatic Cancer30 pag-aaral
- Kanser sa Baga26 pag-aaral
- Colorectal Cancer24 pag-aaral
- Sakit sa Puso at Ugat ng Dugo22 pag-aaral
- Kanser ng Endometrium20 pag-aaral
- Acute Myeloid Leukemia20 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.